Catalyst Wire Dossier Catalyst Wire Dossier

GVGH iNTS-TCV vaccine

iNTS-TCV vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GVGH iNTS-TCV vaccine, covering 2025-11-28 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants [Phase 2]

See pricing